摘要 |
<p>A method of reducing aluminum concentrations in the central nervous system of a subject (e.g., a patient afflicted with Alzheimer's disease or at risk of developing Alzheimer's disease) comprises administering to subject a PYY receptor agonist in an amount effective to reduce aluminum concentrations, levels or amounts in the central nervous system of the subject. Compositions useful for carrying out the method are also disclosed.</p> |